Yu, Liping
Ye, Xiaojun
Yang, Zhaojun
Yang, Wenying
Zhang, Bo https://orcid.org/0000-0003-3060-7850
,
Funding for this research was provided by:
Key Programme (2017YFC1309705)
Article History
Received: 4 May 2020
Accepted: 2 September 2020
First Online: 11 September 2020
Ethics approval and consent to participate
: The China National Diabetes and Metabolic Disorders study was approved by the Ethics Review Board of China-Japan Friendship Hospital and the ethics committee of local institutions. The secondary objectives of the China National Diabetes and Metabolic Disorders study included the analysis of ECG abnormalities which was approved during the original ethical review.
: Not applicable.
: The authors have no competing interests.